Carey Olsen's Guernsey funds team and funds service provider JTC have assisted CEIBA Investments Limited to help bring its listing on the Specialist Fund Segment (SFS) of the London Stock Exchange to fruition.
CEIBA is the largest listed foreign investor offering dedicated investment opportunities directly into Cuba. Its investment portfolio currently includes a modern office complex in Cuba, four existing hotels and a development of a 400-room hotel. On admission to the SFS on 22 October, CEIBA had a market capitalisation of approximately £137 million.
Carey Olsen partner Ben Morgan led the team advising CEIBA on its listing and was assisted by Senior Associate Chris Hutley-Hurst and Associate Felicity White.
Mr Morgan said: "This listing clearly represents a key step for a highly innovative fund that will open up further capital raising opportunities to maintain its momentum in the Cuban real estate market. It is also further evidence of Guernsey’s appeal for listed vehicles, and we continue to see a strong pipeline of work in this area."
Pictured: Ben Morgan
John Herring, Chairman of CEIBA Investments Limited, said: "We are very pleased to have successfully listed the company on the SFS of the London Stock Exchange, which means that we are able to look forward and continue to build on our record of successful investment in Cuba."
James Tracey, Managing Director of JTC in Guernsey commented: "We have a relationship with CEIBA spanning over a decade, and it is a privilege to be able to support the company in the latest stage of its journey through a landmark listing on the SFS in London. Not only is this listing a good news story for CEIBA, it’s also a strong reflection of our AIFM complementary services and the strength of the Guernsey regime for specialist fund and corporate work."
Pictured top: James Tracey
Once your comment has been submitted, it won’t appear immediately. There is no need to submit it more than once. Comments are published at the discretion of Bailiwick Publishing, and will include your username.
There are no comments for this article.